Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drugs in development

    Project Inform Perspective
    |May 29, 2003
    PubMed
    Summary
    This summary is machine-generated.

    New anti-HIV drug development faces setbacks, delaying some therapies. However, promising treatments continue rapid advancement, offering hope for effective HIV therapies.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Everything antiretroviral: 5th IAS conference, Cape Town, South Africa.

    Project Inform perspective·2012
    Same journal

    Well implemented, President Obama's national HIV/AIDS strategy is precisely what is needed to further control HIV/AIDS.

    Project Inform perspective·2011
    Same journal

    Finding health care; preparing for the future.

    Project Inform perspective·2011
    Same journal

    Protecting people with HIV in the California budget.

    Project Inform perspective·2010
    Same journal

    Current drugs in clinical study.

    Project Inform perspective·2010
    Same journal

    HIV treatment information.

    Project Inform perspective·2010
    See all related articles

    Area of Science:

    • Virology
    • Pharmacology
    • Drug Development

    Background:

    • Review of novel anti-HIV drug candidates in development.
    • Recent progress in HIV therapy research.

    Discussion:

    • Setbacks encountered in the development pipeline for certain anti-HIV medications.
    • Analysis of factors contributing to development delays and stoppages.

    Key Insights:

    • Some novel anti-HIV therapies are experiencing significant development hurdles.
    • Promising anti-HIV drug candidates are progressing rapidly through clinical trials.

    Outlook:

    • Continued monitoring of HIV drug development is crucial.
    • Potential for new, effective HIV treatments remains high despite challenges.